SCHEMBL13298492

SCHEMBL13298492

c1ccc([SiH2]c2ccc3c(-c4ccc(-c5cccc6ccccc56)cc4)c4ccccc4c(-c4cc5ccccc5c5ccccc45)c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 1/20 0.37
▸ MCL1 Q07820 1/20 0.35
▸ ACMSD Q8TDX5 1/20 0.35
▸ ENPP3 O14638 1/20 0.35
▸ ENPP1 P22413 1/20 0.35
▸ CA12 O43570 2/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA9 Q16790 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ GPR84 Q9NQS5 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298504 1.00 SOS1 (0.37) SOS1MCL1ACMSDENPP3ENPP1
SCHEMBL13298519 0.95 SOS1 (0.37) SOS1MCL1ACMSDENPP3ENPP1
SCHEMBL13298521 0.95 SOS1 (0.37) SOS1MCL1ACMSDENPP3ENPP1
SCHEMBL13298586 0.93 SOS1 (0.37) SOS1MCL1ACMSDENPP3ENPP1
SCHEMBL13298580 0.93 SOS1 (0.37) SOS1MCL1ACMSDENPP3ENPP1
SCHEMBL13298502 0.92 MCL1 (0.38) SOS1MCL1ACMSDENPP3ENPP1
SCHEMBL13298500 0.92 MCL1 (0.38) SOS1MCL1ACMSDENPP3ENPP1
SCHEMBL13298551 0.92 SOS1 (0.36) SOS1MCL1ACMSDCA12CA1
SCHEMBL13298547 0.92 SOS1 (0.36) SOS1MCL1ACMSDCA12CA1
SCHEMBL13298488 0.90 ALOX5 (0.38) SOS1ALDH1A1HPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 SOS1 2366/4885MCL1 3996/4885ACMSD 191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback